Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study

Circulation

Volumn 102, Issue 15, 2000, Pages 1755-1760

  Muhlestein, Joseph B ^a   Anderson, Jeffrey L ^a   Carlquist, John F ^a   Salunkhe, Kirti ^a   Horne, Benjamin D ^a   Pearson, Robert R ^a   Bunch, T Jared ^a   Allen, Ann ^a   Trehan, Sanjeev ^a   Nielson, Cindy ^a  

^a LDS HOSPITAL   (United States)

Author keywords

Antibiotics; Chlamydia pneumoniae; Coronary disease

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART ARREST; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0034633839     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.15.1755     Document Type: Article

References (36)

1. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
2. Atherosclerosis: An inflammatory disease
3. Cell biology of atherosclerosis
4. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research
5. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis
6. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
7. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
8. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
9. Infections caused by Chlamydia pneumoniae strain TWAR
10. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-79
11. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
12. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
13. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
14. Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease
15. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary heart disease
16. Chlamydia pneumoniae, strain TWAR, and atherosclerosis
17. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
18. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks in atheromatous plaques
19. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
20. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
21. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: The Chlamydia pneumoniael Atherosclerosis Study Group
22. Rabbit model for Chlamydia pneumoniae infection
23. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
24. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)
25. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
26. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
27. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
28. Induction of macrophage foam cell formation by Chlamydia pneumoniae
29. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
30. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis
31. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide
32. Vascular heat shock protein expression in response to stress: Endocrine and autonomic regulation of this age-dependent response
33. Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis
34. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression
35. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
36. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study